Mohamed Abou‐El‐Enein

Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial

Andy Roemhild, Natalie Otto, Guido Moll et al. · BMJ · 2020 · 173 citations · Full text

Life Sciences, Immunology, Nephrology +14

Overcoming Challenges Facing Advanced Therapies in the EU Market

Mohamed Abou‐El‐Enein, Ahmed Elsanhoury, Petra Reinke · Cell stem cell · 2016 · 134 citations · Full text

Public Affairs, Health Policy, Clinical Medicine +5

Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs

Mohamed Abou‐El‐Enein, Andy Römhild, Daniel R. Kaiser et al. · Cytotherapy · 2013 · 84 citations

Engineering, Manufacturing Engineering, Pharmacoeconomics +16

Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals

Magdi Elsallab, Christopher A. Bravery, Mohamed Abou‐El‐Enein · Molecular Therapy — Methods & Clinical Development · 2020 · 54 citations · Full text

Pharmacy, Biotechnology, Pharmaceutical Policy +17

Telbivudine in Chronic Lymphocytic Myocarditis and Human Parvovirus B19 Transcriptional Activity

Sophie Van Linthout, Ahmed Elsanhoury, Oliver Klein et al. · ESC Heart Failure · 2018 · 49 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15